Related references
Note: Only part of the references are listed.Trends in big data analyses by multicenter collaborative translational research in psychiatry
Toshiaki Onitsuka et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
Ryuji Furihata et al.
SLEEP MEDICINE (2022)
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
Kazuyoshi Ogasawara et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2022)
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
Norio Yasui-Furukori et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2022)
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project
Naoki Hashimoto et al.
ASIAN JOURNAL OF PSYCHIATRY (2021)
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study
Shusuke Numata et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2021)
Polypharmacy in schizophrenia
Lone Baandrup
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Mediating role of cognition and social cognition on creativity among patients with schizophrenia and healthy controls: Revisiting the Shared Vulnerability Model
Agurne Sampedro et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia
Tetsuya Shiga et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
George A. Keepers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness ofGuidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study
Hitoshi Iida et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Social anxiety and negative symptoms as the characteristics of patients with schizophrenia who show competence-performance discrepancy in social functioning
Takahiro Nemoto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Effect of adding individualized occupational therapy to standard care on rehospitalization of patients with schizophrenia: A 2-year prospective cohort study
Takeshi Shimada et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study
Yoshikazu Takaesu et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey
Min Dong et al.
ASIAN JOURNAL OF PSYCHIATRY (2019)
Informing real-world practice with real-world evidence: the value of PRECIS-2
Gila Neta et al.
BMC MEDICINE (2018)
Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark: A Nation-wide pharmacoepidemiological study
S. G. Pristed et al.
PSYCHIATRY RESEARCH (2017)
The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders - what's next?
Assen Jablensky et al.
AUSTRALASIAN PSYCHIATRY (2017)
Psychotropic dose equivalence in Japan
Toshiya Inada et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function
Shin Ogino et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
Nevena Divac et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients
Hikaru Hori et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009
Takashi Yoshio et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?
Julie Eve Desmarais et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
The rise and fall of the atypical antipsychotics
Tim Kendall
BRITISH JOURNAL OF PSYCHIATRY (2011)
Dopamine D2 Receptor Occupancy and Clinical Effects A Systematic Review and Pooled Analysis
Hiroyuki Uchida et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009
Y. -T. Xiang et al.
PHARMACOPSYCHIATRY (2011)
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia
Shin Ogino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine
Pal Gjerden et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Anticholinergic use in hospitalised schizophrenic patients in Belgium
Marc De Hert et al.
PSYCHIATRY RESEARCH (2007)
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics - a European study
W. J. Broekema et al.
PHARMACY WORLD & SCIENCE (2007)
Antipsychotic medication and cognitive function in schizophrenia
Hiroaki Hori et al.
SCHIZOPHRENIA RESEARCH (2006)
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy
RM Carnahan et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Association of anticholinergic load with impairment of complex attention and memory in schizophrenia
MJ Minzenberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Share Paper
